Publicaciones (98) Publicaciones de LUIS CARREÑO PÉREZ

2020

  1. Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study

    Arthritis Care and Research, Vol. 72, Núm. 6, pp. 822-828

2018

  1. Agreement between semiquantitative and quantitative Doppler scoring systems for the assessment of synovial pathological vascularisation in rheumatoid arthritis

    Clinical and experimental rheumatology, Vol. 36, Núm. 6, pp. 970-975

2017

  1. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, singleblind, placebo-controlled phase Ib/IIa clinical trial

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 196-202

  2. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

2016

  1. How does a cadaver model work for testing ultrasound diagnostic capability for rheumatic-like tendon damage?

    Rheumatology International, Vol. 36, Núm. 6, pp. 863-869

  2. Multiobserver reliability of ultrasound assessment of salivary glands in patients with established primary sjögren syndrome

    Journal of Rheumatology, Vol. 43, Núm. 10, pp. 1858-1863

  3. Structural damage in rheumatoid arthritis: Comparison between tendon damage evaluated by ultrasound and radiographic damage

    Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1042-1046

  4. The feet in systemic lupus erythematosus; are we underestimating their involvement and functional impact?

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 4, pp. 609-617

  5. The value of biological therapies in the treatment of rheumatic chronic diseases. A systematic review of its pharmacoeconomic evidence in Spain

    Pharmacoeconomics - Spanish Research Articles, Vol. 13, Núm. 2, pp. 69-89

  6. Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?

    Rheumatology International, Vol. 36, Núm. 3, pp. 387-396

2015

  1. Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment

    Clinical Rheumatology, Vol. 34, Núm. 5, pp. 935-942

  2. Comparison of two ELISA versions for infliximab serum levels in patients diagnosed with ankylosing spondylitis

    Rheumatology International, Vol. 35, Núm. 6, pp. 1021-1025

  3. Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]

    Seminars in Arthritis and Rheumatism

  4. Impact of musculoskeletal ultrasound on clinical practice in paediatric rheumatology

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 4, pp. 583-587

  5. Investigating the link between disease activity and infliximab serum levels in rheumatoid arthritis patients

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 6, pp. 805-811

  6. Juvenile, adult and late-onset systemic lupus erythematosus: A long-term follow-up study from a geographic and ethnically homogeneous population

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 6, pp. 788-794

  7. Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis

    Rheumatology (United Kingdom), Vol. 54, Núm. 8, pp. 1408-1414

  8. Relation of Doppler ultrasound synovitis versus clinical synovitis with changes in native complement component levels in rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 2, pp. 141-145

2014

  1. Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice

    Clinical and Experimental Rheumatology, Vol. 32, Núm. 6, pp. 942-948

  2. Does ultrasound-scored synovitis depend on the pharmacokinetics of subcutaneous anti-TNF agents in patients with rheumatoid arthritis?

    Rheumatology (United Kingdom), Vol. 53, Núm. 11, pp. 2088-2094